Companies · Other Health Care

SMRxT, INC.

OVERLAND PARK · Other Health Care

Diligence memoA one-page analyst read on SMRxT, INC. — recommendation, valuation, rhythm, risks.
$13.3M
Total raised · real
5
Rounds
0.3×
Latest step-up
Top 22%
Sector rank · raised
Series A
Latest stage · inferred · Wed Jul 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

SMRxT, INC. looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.20× the median modeled value of Series A Other Health Care companies in 2019–2021 (164 peers) — value vs value, same stage and era.
Dormant
  • Last raise 6.0 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

SMRxT, INC. is one of 5376 Other Health Care companies tracked from OVERLAND PARK. By capital raised it ranks in the upper tier (ahead of 79% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeed · 2012-11-19 Raised $1.4M (real) Modeled valuation $34M (est)$1.4M$34MSeed2012Seed · 2014-07-01 Raised $4.0M (real) Modeled valuation $99M (est)$4.0M$99MSeed2014Seed · 2015-07-01 Raised $3.0M (real) Modeled valuation $74M (est)$3.0M$74MSeed2015Series A · 2017-07-01 Raised $7.0M (real) Modeled valuation $141M (est)$7.0M$141MSeries A2017Series A · 2017-07-25 Raised $3.9M (real) Modeled valuation $80M (est)$3.9M$80MSeries A2017Series A · 2020-07-01 Raised $1.0M (real) Modeled valuation $20M (est)$1.0M$20MSeries A2020+$4.0M+$3.0M+$7.0M+$3.9M+$1.0MCumulative $20M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$1.4M · 2012
Seed extension$4.0M · 2014
Seed extension$3.0M · 2015
Series A$7.0M · 2017
Series A extension$3.9M · 2017
Series A extension$1.0M · 2020

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$20.2M
Base estimate est.
$1.3M
Conservative case
$109.6M
Upside case
$4.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $33.7M · 2012-11-192012Seed · modeled $99.1M · 2014-07-01Seed · modeled $74.4M · 2015-07-01Series A · modeled $141.3M · 2017-07-01Series A · modeled $79.6M · 2017-07-25Series A · modeled $20.2M · 2020-07-012020
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.43×/yr
Annual markup
1.80×/yr upside case
6.0 yr
Elapsed time used
6.0 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
18 mo
Avg between rounds
$1.7M/yr
Capital velocity
13.6 yr
On record since
2012
First round
6
Rounds on file
How it compares to the market

Benchmarked against 5376 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 5.5× above median
This company$13.3M
Sector median$2.4M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.2× of median
This company$1.0M
Sector median$5.6M
Modeled value — vs sector median (estimate, all stages) 0.9× of median
This company$20.2M
Sector median$22.1M

Raised more than 79% of sector peers (real $). Modeled value above 48% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #150 of 164.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0M$100.0MCapital raised (log)iVinci Partners, LLC · Series A Raised $34.8M · modeled $302.7M (est)InvestCo Tabletop, LLC · Series A Raised $15.0M · modeled $302.7M (est)Mediphore, Inc. · Series A Raised $15.0M · modeled $302.7M (est)Oklahoma Proton Center LLC · Series A Raised $14.0M · modeled $282.5M (est)MicroOptx, Inc. · Series A Raised $17.8M · modeled $278.6M (est)ProxsysRx, Inc. · Series A Raised $14.6M · modeled $259.8M (est)Biolux Research Holdings, Inc. · Series A Raised $12.7M · modeled $256.3M (est)Fountain Life Holdings, LLC · Series A Raised $17.1M · modeled $238.4M (est)Equality Management Holdings, LLC · Series A Raised $14.4M · modeled $232.1M (est)Olympus Ascent Investors, LLC · Series A Raised $11.5M · modeled $232.0M (est)EDS Holdco LLC · Series A Raised $12.3M · modeled $221.3M (est)Zipari, Inc. · Series A Raised $29.6M · modeled $208.3M (est)SMRxT, INC. (this company) Raised $13.3M · modeled $20.2M (est)SMRxT, INC.
CompanyStageRaised · realValue · estvs peer med.
iVinci Partners, LLCSeries A$34.8M$302.7M3.00×
InvestCo Tabletop, LLCSeries A$15.0M$302.7M3.00×
Mediphore, Inc.Series A$15.0M$302.7M3.00×
Oklahoma Proton Center LLCSeries A$14.0M$282.5M2.80×
MicroOptx, Inc.Series A$17.8M$278.6M2.76×
ProxsysRx, Inc.Series A$14.6M$259.8M2.57×
Biolux Research Holdings, Inc.Series A$12.7M$256.3M2.54×
Fountain Life Holdings, LLCSeries A$17.1M$238.4M2.36×
Equality Management Holdings, LLCSeries A$14.4M$232.1M2.30×
Olympus Ascent Investors, LLCSeries A$11.5M$232.0M2.30×
EDS Holdco LLCSeries A$12.3M$221.3M2.19×
Zipari, Inc.Series A$29.6M$208.3M2.06×
SMRxT, INC. this companySeries A$13.3M$20.2M0.20×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$1.4M2012-11-19$6.8M$33.7M85%
Seed$4.0M2014-07-01$20.0M$99.1M85%
Seed$3.0M2015-07-01$15.0M$74.4M85%
Series A$7.0M2017-07-01$31.8M$141.3M90%
Series A$3.9M2017-07-25$17.9M$79.6M90%
Series A$1.0M2020-07-01$4.5M$20.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$1.4M2012-11-19
    • First recorded raise — entered as Seed.
    • 23 investors on this round.
  2. Seed$4.0M2014-07-01
    • Raised 19 mo later, in step with the ~14 mo sector norm.
    • Round 2.9× larger than the prior — scaling up.
  3. Seed$3.0M2015-07-01
    • Raised 12 mo later, in step with the ~14 mo sector norm.
    • Round 1.3× smaller than the prior — bridge or down round.
  4. Series A$7.0M2017-07-01
    • Raised again after 24 mo — slower than the ~14 mo sector norm.
    • Round 2.3× larger than the prior — scaling up.
  5. Series A$3.9M2017-07-25
    • Came back fast: 1 mo vs the ~14 mo sector norm.
    • Round 1.8× smaller than the prior — bridge or down round.
    • 16 investors on this round.
  6. Series A$1.0M2020-07-01
    • Raised again after 35 mo — slower than the ~14 mo sector norm.
    • Round 3.9× smaller than the prior — bridge or down round.
Intelligence
2022 ~Q1
Modeled next raise · ~18mo cadence
$1.0M
Modeled next size est.range $1.0M$1.6M
0.3×
Last step-up
$1.7M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
MICHAEL K MCMAHAN2 other2015-07
CHARLES W SCHELLHORN1 other2015-07
GLENN K WALTHALL2017-07
MICHAEL J HUFFER2012-11
STEPHAN J VALTER2012-11
VICTOR J CHU2012-11
Registry & provenance

SMRxT, INC. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1562772
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Innovein, Inc.Other Health CareSeries A$13.3M$20.5Msame sector · same stage
St Cloud Outpatient Surgery LtdOther Health CareSeries A$13.3M$17.2Msame sector · same stage
IGGBO, Inc.Other Health CareSeries A$13.1M$23.9Msame sector · same stage
Mednition, Inc.Other Health CareSeries A$13.0M$18.8Msame sector · same stage
Integrity Implants Inc.Other Health CareSeries A$13.6M$21.2Msame sector · same stage
Mardil, Inc.Other Health CareSeries A$12.8M$18.2Msame sector · same stage
Aletheia BioTherapeutics, LLCOther Health CareSeries A$12.7M$22.6Msame sector · same stage
Enable My Child, Ltd Dba HelloheroOther Health CareSeries A$12.3M$23.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
MedRx Global, Inc.Other Health CarePre-Seed$27.7M88%
MVRx, Inc.Other Health CareSeries A$118.7M86%
CardioNXT, Inc.Other Health CareSeed$74.4M85%
Smilink Ltd.Other Health CareSeed$48.6M85%
FundRx, Inc.Other Health CareSeed$34.5M85%
Remedtx, Inc.Other Health CarePre-Seed$1.4M84%
NexGelRx, Inc.Other Health CareSeed$3.0M84%
Nxt Biomedical, LlcOther Health CareSeries A$187.4M84%
Frequently asked
How much funding has SMRxT, INC. raised?
SMRxT, INC. has raised approximately $13.3M in disclosed capital across 5 recorded financing rounds, aggregated from public filings.
What is SMRxT, INC.'s estimated valuation?
Provath's modeled valuation for SMRxT, INC. is approximately $20.2M (modeled range $1.3M–$109.6M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is SMRxT, INC. at?
SMRxT, INC.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Wed Jul 01.
What does SMRxT, INC. do and where is it based?
SMRxT, INC. operates in the Other Health Care sector, based in OVERLAND PARK.
Explore related

See where SMRxT, INC. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at SMRxT, INC., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.